Wang C, Horby PW, Hayden FG, Gao GF. A novel coronavirus outbreak of global health concern. Lancet. 2020;395(10223):470–3. https://doi.org/10.1016/S0140-6736(20)30185-9.
CAS Article PubMed PubMed Central Google Scholar
2.Obi AT, Barnes GD, Napolitano LM, Henke PK, Wakefield TW. Venous thrombosis epidemiology, pathophysiology, and anticoagulant therapies and trials in severe acute respiratory syndrome coronavirus 2 infection. J Vasc Surg Venous Lymphat Disord. 2021;9(1):23–35. https://doi.org/10.1016/j.jvsv.2020.08.030.
3.Middeldorp S, Coppens M, van Haaps TF, Foppen M, Vlaar AP, Muller MCA, et al. Incidence of venous thromboembolism in hospitalized patients with COVID-19. J Thromb Haemost. 2020;18(8):1995–2002. https://doi.org/10.1111/jth.14888.
CAS Article PubMed PubMed Central Google Scholar
4.Klok FA, Kruip M, van der Meer NJM, Arbous MS, Gommers D, Kant KM, et al. Incidence of thrombotic complications in critically ill ICU patients with COVID-19. Thromb Res. 2020;191:145–7. https://doi.org/10.1016/j.thromres.2020.04.013.
CAS Article PubMed PubMed Central Google Scholar
5.Kunutsor SK, Laukkanen JA. Incidence of venous and arterial thromboembolic complications in COVID-19: a systematic review and meta-analysis. Thromb Res. 2020;196:27–30. https://doi.org/10.1016/j.thromres.2020.08.022.
CAS Article PubMed PubMed Central Google Scholar
6.Al-Ani F, Chehade S, Lazo-Langner A. Thrombosis risk associated with COVID-19 infection. A scoping review Thrombosis Research. 2020;192:152–60. https://doi.org/10.1016/j.thromres.2020.05.039.
CAS Article PubMed Google Scholar
7.Bilaloglu S, Aphinyanaphongs Y, Jones S, Iturrate E, Hochman J, Berger JS. Thrombosis in hospitalized patients with COVID-19 in a New York City health system. JAMA. 2020;324(8):799–801. https://doi.org/10.1001/jama.2020.13372.
CAS Article PubMed PubMed Central Google Scholar
8.Thachil J, Cushman M, Srivastava A. A proposal for staging COVID-19 coagulopathy. Res Pract Thromb Haemost. 2020;4(5):731–6. https://doi.org/10.1002/rth2.12372.
CAS Article PubMed PubMed Central Google Scholar
9.Llitjos JF, Leclerc M, Chochois C, Monsallier JM, Ramakers M, Auvray M, et al. High incidence of venous thromboembolic events in anticoagulated severe COVID-19 patients. J Thromb Haemost. 2020;18(7):1743–6. https://doi.org/10.1111/jth.14869.
10.Wichmann D, Sperhake JP, Lutgehetmann M, Steurer S, Edler C, Heinemann A, et al. Autopsy findings and venous thromboembolism in patients with COVID-19: a prospective cohort study. Ann Intern Med. 2020;173(4):268–77. https://doi.org/10.7326/M20-2003.
11.Cavalcanti DD, Raz E, Shapiro M, Dehkharghani S, Yaghi S, Lillemoe K, et al. Cerebral venous thrombosis associated with COVID-19. AJNR Am J Neuroradiol. 2020;41(8):1370–6. https://doi.org/10.3174/ajnr.A6644.
CAS Article PubMed PubMed Central Google Scholar
12.Cheung S, Quiwa JC, Pillai A, Onwu C, Tharayil ZJ, Gupta R. Superior mesenteric artery thrombosis and acute intestinal ischemia as a consequence of COVID-19 infection. Am J Case Rep. 2020;21: e925753. https://doi.org/10.12659/AJCR.925753.
Article PubMed PubMed Central Google Scholar
13.Szegedi I, Orban-Kalmandi R, Csiba L, Bagoly Z. Stroke as a potential complication of COVID-19-associated coagulopathy: a narrative and systematic review of the literature. J Clin Med. 2020;9:10. https://doi.org/10.3390/jcm9103137.
14.Alonso MN, Mata-Forte T, García-León N, Vullo PA, Ramirez-Olivencia G, Estébanez M, et al. Incidence, characteristics, laboratory findings and outcomes in acro-ischemia in COVID-19 patients. Vasc Health Risk Manag. 2020;16:467–78. https://doi.org/10.2147/vhrm.S276530.
CAS Article PubMed PubMed Central Google Scholar
15.Philipponnet C, Aniort J, Chabrot P, Souweine B, Heng AE. Renal artery thrombosis induced by COVID-19. Clin Kidney J. 2020;13(4):713. https://doi.org/10.1093/ckj/sfaa141.
CAS Article PubMed PubMed Central Google Scholar
16.Helms J, Tacquard C, Severac F, Leonard-Lorant I, Ohana M, Delabranche X, et al. High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study. Intensive Care Med. 2020;46(6):1089–98. https://doi.org/10.1007/s00134-020-06062-x.
17.Hamade A, Jambert L, Tousch J, Talbot M, Dervieux B, Nazer TE, et al. Systematic duplex ultrasound screening in conventional units for COVID-19 patients with follow-up of 5 days. J Vasc Surg Venous Lymphat Disord. 2020. https://doi.org/10.1016/j.jvsv.2020.11.019.
Article PubMed PubMed Central Google Scholar
18.Anti-thrombotics for adults hospitalized with COVID-19 (ACTIV-4). https://ClinicalTrials.gov/show/NCT04505774.
19.Zarychanski R. Therapeutic anticoagulation in critically ill patients with Covid-19 – preliminary report. medRxiv. 2021;2021(03):10.21252749. https://doi.org/10.1101/2021.03.10.21252749.
20.Blann AD, Lip GY. Virchow’s triad revisited: the importance of soluble coagulation factors, the endothelium, and platelets. Thromb Res. 2001;101(4):321–7. https://doi.org/10.1016/s0049-3848(00)00419-9.
CAS Article PubMed Google Scholar
21.Bikdeli B, Madhavan MV, Jimenez D, Chuich T, Dreyfus I, Driggin E, et al. COVID-19 and thrombotic or thromboembolic disease: implications for prevention, antithrombotic therapy, and follow-up: JACC state-of-the-art review. J Am Coll Cardiol. 2020;75(23):2950–73. https://doi.org/10.1016/j.jacc.2020.04.031.
CAS Article PubMed PubMed Central Google Scholar
22.Poissy J, Goutay J, Caplan M, Parmentier E, Duburcq T, Lassalle F, et al. Pulmonary embolism in patients with COVID-19: awareness of an increased prevalence. Circulation. 2020;142(2):184–6. https://doi.org/10.1161/circulationaha.120.047430.
CAS Article PubMed Google Scholar
23.Nicolai L, Leunig A, Brambs S, Kaiser R, Weinberger T, Weigand M, et al. Immunothrombotic dysregulation in COVID-19 pneumonia is associated with respiratory failure and coagulopathy. Circulation. 2020;142(12):1176–89. https://doi.org/10.1161/CIRCULATIONAHA.120.048488.
CAS Article PubMed PubMed Central Google Scholar
24.Ackermann M, Verleden SE, Kuehnel M, Haverich A, Welte T, Laenger F, et al. Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in Covid-19. N Engl J Med. 2020;383(2):120–8. https://doi.org/10.1056/NEJMoa2015432.
CAS Article PubMed PubMed Central Google Scholar
25.Kamel MH, Yin W, Zavaro C, Francis JM, Chitalia VC. Hyperthrombotic milieu in COVID-19 patients. Cells. 2020;9(11):2392. https://doi.org/10.3390/cells9112392.
CAS Article PubMed Central Google Scholar
26.Al-Samkari H, Karp Leaf RS, Dzik WH, Carlson JCT, Fogerty AE, Waheed A, et al. COVID-19 and coagulation: bleeding and thrombotic manifestations of SARS-CoV-2 infection. Blood. 2020;136(4):489–500. https://doi.org/10.1182/blood.2020006520.
27.Panigada M, Bottino N, Tagliabue P, Grasselli G, Novembrino C, Chantarangkul V, et al. Hypercoagulability of COVID-19 patients in intensive care unit: a report of thromboelastography findings and other parameters of hemostasis. J Thromb Haemost. 2020;18(7):1738–42. https://doi.org/10.1111/jth.14850.
28.Boschiero MN, Carvalho TA, Marson FAL. Retraction in the era of COVID-19 and its influence on evidence-based medicine: is science in jeopardy? Pulmonology. 2021;27(2):97–106. https://doi.org/10.1016/j.pulmoe.2020.10.011.
29.Varga Z, Flammer AJ, Steiger P, Haberecker M, Andermatt R, Zinkernagel AS, et al. Endothelial cell infection and endotheliitis in COVID-19. Lancet. 2020;395(10234):1417–8. https://doi.org/10.1016/S0140-6736(20)30937-5.
CAS Article PubMed PubMed Central Google Scholar
30.Maccio A, Madeddu C, Caocci G, La Nasa G. Multifactorial pathogenesis of COVID-19-related coagulopathy: can defibrotide have a role in the early phases of coagulation disorders? J Thromb Haemost. 2020;18(11):3106–8. https://doi.org/10.1111/jth.15021.
CAS Article PubMed Google Scholar
31.Milford EM, Reade MC. Resuscitation fluid choices to preserve the endothelial glycocalyx. Crit Care. 2019;23(1):77. https://doi.org/10.1186/s13054-019-2369-x.
Article PubMed PubMed Central Google Scholar
32.Haywood-Watson RJ, Holcomb JB, Gonzalez EA, Peng Z, Pati S, Park PW, et al. Modulation of syndecan-1 shedding after hemorrhagic shock and resuscitation. PLoS ONE. 2011;6(8): e23530. https://doi.org/10.1371/journal.pone.0023530.
CAS Article PubMed PubMed Central Google Scholar
33.Goshua G, Pine AB, Meizlish ML, Chang CH, Zhang H, Bahel P, et al. Endotheliopathy in COVID-19-associated coagulopathy: evidence from a single-centre, cross-sectional study. Lancet Haematol. 2020;7(8):e575–82. https://doi.org/10.1016/S2352-3026(20)30216-7.
Article PubMed PubMed Central Google Scholar
34.Meizlish ML, Pine AB, Goshua G, Chang CH, Zhang H, Bishai J, et al. Circulating markers of angiogenesis and endotheliopathy in COVID-19. medRxiv. 2020;10:2045894020966547. https://doi.org/10.1101/2020.06.29.20140376.
35.Fraser DD, Patterson EK, Slessarev M, Gill SE, Martin C, Daley M, et al. Endothelial injury and glycocalyx degradation in critically ill coronavirus disease 2019 patients: implications for microvascular platelet aggregation. Crit Care Explor. 2020;2(9): e0194. https://doi.org/10.1097/CCE.0000000000000194.
Article PubMed PubMed Central Google Scholar
36.Yamaoka-Tojo M. Vascular endothelial glycocalyx damage in COVID-19. Int J Mol Sci. 2020;21(24):9712. https://doi.org/10.3390/ijms21249712.
CAS Article PubMed Central Google Scholar
37.Mackman N, Tilley RE, Key NS. Role of the extrinsic pathway of blood coagulation in hemostasis and thrombosis. Arterioscler Thromb Vasc Biol. 2007;27(8):1687–93. https://doi.org/10.1161/ATVBAHA.107.141911.
留言 (0)